4th international conference on tumor progression and therapeutic resistance: meeting report

Cancer Biology & Therapy
Varun V Prabhu, Wafik S El-Deiry

Abstract

The fourth international conference on tumor progression and therapeutic resistance organized in association with GTCbio was held in Boston, MA from March 9 to 11, 2014. The meeting attracted a diverse group of experts in the field of cancer biology, therapeutics and medical oncology from academia and industry. The meeting addressed the current challenges in the treatment of cancer including tumor heterogeneity, therapy resistance and metastasis along with the need for improved biomarkers of tumor progression and clinical trial design. Keynote speakers included Clifton Leaf, Editor at Fortune Magazine, Dr. Mina Bissell from the Lawrence Berkeley National Laboratory and Dr. Levi Garraway from the Dana Farber Cancer Institute. The meeting featured cutting edge tools, preclinical models and the latest basic, translational and clinical research findings in the field.

References

Oct 1, 1976·Science·P C Nowell
Dec 1, 1982·Proceedings of the National Academy of Sciences of the United States of America·R Dalla-FaveraC M Croce
Nov 19, 1993·Cell·W S el-DeiryB Vogelstein
Jun 28, 2000·Nucleic Acids Research·A JanzA Thomas-Tikhonenko
Jul 13, 2002·International Journal of Cancer. Journal International Du Cancer·Christine RebischungPierre Laurent-Puig
Dec 20, 2005·The Journal of Investigative Dermatology. Symposium Proceedings·Nikolas K Haass, Meenhard Herlyn
Jul 13, 2006·Proceedings of the National Academy of Sciences of the United States of America·Wenge WangWafik S El-Deiry
Jul 25, 2006·Cancer Biology & Therapy·Diane R Fels, Constantinos Koumenis
Aug 1, 2006·Nature Genetics·Michael DewsAndrei Thomas-Tikhonenko
Feb 13, 2007·Nature Genetics·Roman K ThomasLevi A Garraway
Mar 31, 2007·Nature Methods·Genee Y LeeMina J Bissell
Mar 13, 2008·Proceedings of the National Academy of Sciences of the United States of America·Sarah DonaldHeidi C E Welch
Jun 17, 2008·Cell·Sandra S McAllisterRobert A Weinberg
Jun 9, 2009·Proceedings of the National Academy of Sciences of the United States of America·Tsukasa Shibue, Robert A Weinberg
Jul 28, 2009·Cell·Ravshan BurikhanovVivek M Rangnekar
Nov 20, 2009·PloS One·Laura E MacConaillLevi A Garraway
Feb 6, 2010·Proceedings of the National Academy of Sciences of the United States of America·Nish PatelBruce R Zetter
Mar 17, 2010·The Journal of Investigative Dermatology·Meenhard Herlyn, Mizuho Fukunaga-Kalabis
Apr 7, 2010·Breast Cancer Research and Treatment·Maria Aparecida NagaiFernando A Soares
Apr 15, 2010·The Journal of Clinical Investigation·Anil K SoodSusan K Lutgendorf
Oct 16, 2010·Annals of the New York Academy of Sciences·Robert Coleman
Nov 26, 2010·Nature·Cory M JohannessenLevi A Garraway
Dec 22, 2010·Journal of Cell Science·Virginia A SpencerMina J Bissell
Jan 27, 2011·The Journal of Clinical Investigation·Moshe ElkabetsSandra S McAllister
Feb 8, 2011·Cell Stem Cell·Theresa A ProiaCharlotte Kuperwasser
Mar 18, 2011·Pigment Cell & Melanoma Research·Susan E ZabierowskiMeenhard Herlyn
Apr 19, 2011·Proceedings of the National Academy of Sciences of the United States of America·Christine L ChafferRobert A Weinberg
Jul 8, 2011·Science Translational Medicine·Juliann ChmieleckiWilliam Pao
Aug 20, 2011·Science·David A SolomonTodd Waldman
Sep 24, 2011·Proceedings of the National Academy of Sciences of the United States of America·Patricia J KellerCharlotte Kuperwasser
Feb 22, 2012·Trends in Genetics : TIG·Ondrej PodlahaFranziska Michor
Feb 24, 2012·The New England Journal of Medicine·Jeffrey A SosmanAntoni Ribas
May 23, 2012·Cell·Serena Nik-ZainalUNKNOWN Breast Cancer Working Group of the International Cancer Genome Consortium
Sep 12, 2012·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Sören LehmannPer-Ola Andersson

❮ Previous
Next ❯

Citations

Jul 27, 2017·Journal of Evidence-based Complementary & Alternative Medicine·Mekonnen Sisay, Tigist Gashaw

❮ Previous
Next ❯

Methods Mentioned

BETA
exome sequencing
biopsy
RNA-seq
nucleotide exchange
xenografts
transgenic
flow cytometry
chromosomal aberrations
fluorescence-activated cell sorting
FACS

Software Mentioned

OncoMap
CanSeq
cBioportal

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.